Abstract:AIM To assess the effect of ACE inhibitor and Ang II type 1 (AT1) receptor antagonist in preventing hepatic fibrosis caused by CCl4 administration in rats; to investigate whether or not there are expression of AT 1 receptors on hepatic stellate cells; and to observe the effect of Ang II on proliferation and ECM synthesis of cultured HSCs.METHODS Studies were conducted in male Sprague-Dawley rats. Except for the hepatofibrotic model group and the control group, in three treated groups, either enalapril (5 mg/kg), or losartan (10 mg/kg), or enalapril + losartan were given to the fibrotic rats by daily gavage, and saline vehicle was given to model and normal control rats, After 6 weeks, liver fibrosis was assessed directly by hepatic morphometric analysis, which has been considered the gold standard for the quantification of fibrosis, The expressions of AT 1 receptors and (alpha -mooth muscle actin, alpha -SMA) in liver tissue or isolated hepatic stellate cells (HSCs) were detected by immunohistochemical techniques, The effect of Ang IT. on HSC proliferation was determined by MTT method, Effect of Ang IT on collagen synthesis of HSCs was determined by H-3-proline incorporation.RESULTS Contrasted to the fibrosis in rats of the model group, groups of rats treated with either enalapril or losartan, or a combination of two drugs showed a limited expansion of the interstitium (4.23 +/- 3.70 vs 11.22 +/- 4.79, P<0.05), but no difference was observed among three treated groups (5.38 +/- 3.43, 4.96 +/- 2.96, 4.23 +/- 2.70, P>0.05). Expression of AT 1 receptors was found in fibrotic interstitium of fibrotic rats, whereas in normal control rats they were limited to vasculature only to a very slight degree, AT 1 receptors were also expressed on activated HSCs in the culture, At concentrations from 10(-9) to 10(-5) mol/L, Ang II stimulated HSC proliferation in culture in a dose-dependent manner, Increasing Ang II concentrations produced corresponding increases in H-3-proline incorporation, Differences among groups were significant,CONCLUSION Angiotensin-converting enzyme inhibitors and AT 1 blocker may slow the progression of hepatic fibrosis; activated HSCs express AT 1 receptors, and Ang II can stimulate the proliferation and collagen synthesis of HSCs in a dose-dependent manner; and activation of RAS may be related to hepatic fibrogenesis induced by CCl4.

Levistilide A reverses rat hepatic fibrosis by suppressing angiotensin II‐induced hepatic stellate cells activation

Liver Fibrosis Therapy Based on Biomimetic Nanoparticles Which Deplete Activated Hepatic Stellate Cells.

Fluorofenidone Attenuates Hepatic Fibrosis By Suppressing The Proliferation And Activation Of Hepatic Stellate Cells

The Regulatory Role of AT1 Receptor on Activated HSCs in Hepatic Fibrogenesis: Effects of RAS Inhibitors on Hepatic Fibrosis Induced by CCl4

Asiaticoside conveys an antifibrotic effect by inhibiting activation of hepatic stellate cells via the Jagged-1/Notch-1 pathway

The effect of antifibrotic drug halofugine on Th17 cells in concanavalin A-induced liver fibrosis.

Effects of renin-angiotensin system inhibitors on hepatic fibrosis

Effect of the regulation of retinoid X receptor-α gene expression on rat hepatic fibrosis.

Effects of all-trans retinioc acid on expressions of COL1α2,MMP-2,TIMP-1, and signaling pathway in TGF-β1-simulated rat hepatic stellate cells

Different Effects of Rat Interferon Alpha, Beta and Gamma on Rat Hepatic Stellate Cell Proliferation and Activation.

Asiatic Acid Inhibits Liver Fibrosis By Blocking Tgf-Beta/Smad Signaling In Vivo And In Vitro

Lactoferrin as a therapeutic agent for attenuating hepatic stellate cell activation in thioacetamide-induced liver fibrosis

Study on the Antifibrotic Effects of Recombinant Shark Hepatical Stimulator Analogue (r-sHSA) in Vitro and in Vivo

Construction of retinoid X receptor-alpha lentivirus vector and its effects on hepatic stellate cells

Effects of Angiotensin II Receptor Blockade on Hepatic Fibrosis in Rats.

Effects of At1 Receptor Antagonist, Losartan, on Rat Hepatic Fibrosis Induced by Ccl4

Resveratrol Alleviates Hepatic Fibrosis in Associated with Decreased Endoplasmic Reticulum Stress-Mediated Apoptosis and Inflammation

Antifibrotic Effects of Luteolin on Hepatic Stellate Cells and Liver Fibrosis by Targeting AKT/mTOR/p70S6K and TGFβ/Smad Signalling Pathways

Sevelamer reverses liver fibrosis by deactivation of hepatic stellate cells

Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis

Expression of angiotensinogen during hepatic fibrogenesis and its effect on hepatic stellate cells.